SARA HEINZ: Open Payments
NPI 1003540634 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 12 payments from 7 companies in 2025. Trend: 2023 $610 · 2024 $0 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $65 |
| GENZYME CORPORATION | 2 | $48 |
| Madrigal Pharmaceuticals | 2 | $40 |
| Celltrion USA Inc. | 1 | $23 |
| Echosens North America, Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: RINVOQ, DUPIXENT, REZDIFFRA, VEGZELMA, Fibroscan, IQIRVO, TREMFYA.
Industry payments across NC — which companies pay providers there.
